预测慢性阻塞性肺疾病中皮质类固醇的反应。血液嗜酸性粒细胞势头渐起。 - Suppr

Suppr

超能文献

Predicting Corticosteroid Response in Chronic Obstructive Pulmonary Disease. Blood Eosinophils Gain Momentum.

作者信息

Singh Dave

机构信息

1 University of Manchester Manchester, United Kingdom and.

2 Medicines Evaluation Unit University Hospital of South Manchester Manchester, United Kingdom.

出版信息

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1098-1100. doi: 10.1164/rccm.201703-0592ED.

DOI:10.1164/rccm.201703-0592ED

PMID:29090962

Abstract

摘要

相似文献

Predicting Corticosteroid Response in Chronic Obstructive Pulmonary Disease. Blood Eosinophils Gain Momentum.预测慢性阻塞性肺疾病中皮质类固醇的反应。血液嗜酸性粒细胞势头渐起。

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1098-1100. doi: 10.1164/rccm.201703-0592ED.

Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.血嗜酸性粒细胞计数与慢性阻塞性肺疾病患者肺炎风险：一项基于患者的荟萃分析。

Lancet Respir Med. 2016 Sep;4(9):731-741. doi: 10.1016/S2213-2600(16)30148-5. Epub 2016 Jul 23.

Eosinophils and Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease.

Arch Bronconeumol. 2016 Oct;52(10):541. doi: 10.1016/j.arbres.2016.05.020. Epub 2016 Jul 18.

Inhaled corticosteroids, eosinophils and chronic obstructive pulmonary disease exacerbations.吸入性糖皮质激素、嗜酸性粒细胞与慢性阻塞性肺疾病急性加重

Arch Bronconeumol. 2016 Oct;52(10):540. doi: 10.1016/j.arbres.2016.04.014. Epub 2016 Jun 24.

A Light in the Darkness? The FLAME Trial, Blood Eosinophils, and Chronic Obstructive Pulmonary Disease.黑暗中的一丝曙光？FLAME试验、血液嗜酸性粒细胞与慢性阻塞性肺疾病

Am J Respir Crit Care Med. 2017 May 1;195(9):1125-1127. doi: 10.1164/rccm.201703-0560ED.

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.不同血液嗜酸性粒细胞计数的慢性阻塞性肺疾病（COPD）患者使用更高吸入糖皮质激素剂量的有效性。

Int J Chron Obstruct Pulmon Dis. 2016 Sep 21;11:2341-2348. doi: 10.2147/COPD.S115132. eCollection 2016.

Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study.慢性阻塞性肺疾病住院加重期血液嗜酸性粒细胞与治疗反应：一项病例对照研究。

Pulm Pharmacol Ther. 2016 Apr;37:89-94. doi: 10.1016/j.pupt.2016.03.004. Epub 2016 Mar 18.

Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink.英国临床实践研究数据库中 COPD 患者血嗜酸性粒细胞计数的稳定性。

COPD. 2017 Aug;14(4):382-388. doi: 10.1080/15412555.2017.1313827. Epub 2017 Jun 1.

[Role of exhaled nitric oxide in predicting steroid response in chronic obstructive pulmonary disease].[呼出一氧化氮在预测慢性阻塞性肺疾病中类固醇反应的作用]

Orv Hetil. 2010 Dec 19;151(51):2083-8. doi: 10.1556/OH.2010.28972.

Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.血嗜酸性粒细胞作为 COPD 患者吸入皮质类固醇激素反应的标志物。

Eur Respir J. 2016 May;47(5):1374-82. doi: 10.1183/13993003.01370-2015. Epub 2016 Feb 25.

引用本文的文献

A Delphi Consensus Project to Capture Greek Experts' Opinion on the Position of Triple Therapies in COPD: Why, When and to Whom.一项德尔菲共识项目，旨在收集希腊专家对慢性阻塞性肺疾病三联疗法的应用立场的意见：为何、何时以及适用于何人。

Int J Chron Obstruct Pulmon Dis. 2025 Feb 26;20:457-471. doi: 10.2147/COPD.S481337. eCollection 2025.

Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation.血液嗜酸性粒细胞与呼出一氧化氮：稳定期慢性阻塞性肺疾病及急性加重期气道嗜酸性粒细胞增多的替代生物标志物

Biomedicines. 2022 Aug 30;10(9):2128. doi: 10.3390/biomedicines10092128.

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.慢性阻塞性肺疾病患者中重度加重的预后危险因素：系统文献回顾。

Respir Res. 2022 Aug 23;23(1):213. doi: 10.1186/s12931-022-02123-5.

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.血液嗜酸性粒细胞作为未来 COPD 加重风险的生物标志物：来自 11 项临床试验的汇总数据。

Respir Res. 2020 Sep 17;21(1):240. doi: 10.1186/s12931-020-01482-1.

Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD.呼出气一氧化氮和血嗜酸性粒细胞计数对 COPD 气道嗜酸性粒细胞评估的预测价值。

Int J Chron Obstruct Pulmon Dis. 2020 Aug 25;15:2025-2035. doi: 10.2147/COPD.S257965. eCollection 2020.

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病临床试验中的血液嗜酸性粒细胞计数

Am J Respir Crit Care Med. 2020 Sep 1;202(5):660-671. doi: 10.1164/rccm.201912-2384PP.

Predicting Pneumonia in Chronic Obstructive Pulmonary Disease. Have We Unraveled the Network of Risks?预测慢性阻塞性肺疾病中的肺炎。我们是否理清了风险网络？

Am J Respir Crit Care Med. 2020 May 1;201(9):1026-1027. doi: 10.1164/rccm.202001-0132ED.

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base.复方福莫特罗和布地奈德/福莫特罗治疗 COPD ：固定剂量复方制剂中乌美溴铵的临床地位。

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619850725. doi: 10.1177/1753466619850725.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验